Skip to main content
. 2020 Oct 8;11:524968. doi: 10.3389/fimmu.2020.524968

Figure 3.

Figure 3

Estimates for the percentage of individuals in the general population predicted to HLA-present resistance mutation-associated neopeptides. For each mutation, the histogram illustrates the percentage of individuals in the 1000G dataset with an IBR < 0.5 (the IBR score is defined in Methods). Mutations on the x-axis are ordered according to decreasing percentages of individuals. We plot only mutations that have been observed in at least five patients (according to COSMIC). Colors indicate the different tumor tissues in which the resistance mutations have been observed; “haema&lymph” stands for hematopoietic and lymphoid tissue. Asterisks (*) mark mutations that have been shown to elicit T-cell responses in previous works (3234).